chr4-3074876-C-CCAGCAGCAGCAGCAGCAGCAGCAGCAG

Variant summary

Our verdict is Likely benign. The variant received -4 ACMG points: 2P and 6B. PP5_ModerateBP3BS1_SupportingBS2

The NM_001388492.1(HTT):​c.84_110dupGCAGCAGCAGCAGCAGCAGCAGCAGCA​(p.Gln29_Gln37dup) variant causes a disruptive inframe insertion change. It is difficult to determine the true allele frequency of this variant because it is of type INS_BIG, and the frequency of such variant types in population databases may be underestimated and unreliable. Variant has been reported in ClinVar as Pathogenic (★).

Frequency

Genomes: 𝑓 0.0058 ( 7 hom., cov: 0)
Exomes 𝑓: 0.0020 ( 29 hom. )
Failed GnomAD Quality Control

Consequence

HTT
NM_001388492.1 disruptive_inframe_insertion

Scores

Not classified

Clinical Significance

Pathogenic criteria provided, single submitter P:1

Conservation

PhyloP100: 4.84

Publications

6 publications found
Variant links:
Genes affected
HTT (HGNC:4851): (huntingtin) Huntingtin is a disease gene linked to Huntington's disease, a neurodegenerative disorder characterized by loss of striatal neurons. This is thought to be caused by an expanded, unstable trinucleotide repeat in the huntingtin gene, which translates as a polyglutamine repeat in the protein product. A fairly broad range of trinucleotide repeats (9-35) has been identified in normal controls, and repeat numbers in excess of 40 have been described as pathological. The huntingtin locus is large, spanning 180 kb and consisting of 67 exons. The huntingtin gene is widely expressed and is required for normal development. It is expressed as 2 alternatively polyadenylated forms displaying different relative abundance in various fetal and adult tissues. The larger transcript is approximately 13.7 kb and is expressed predominantly in adult and fetal brain whereas the smaller transcript of approximately 10.3 kb is more widely expressed. The genetic defect leading to Huntington's disease may not necessarily eliminate transcription, but may confer a new property on the mRNA or alter the function of the protein. One candidate is the huntingtin-associated protein-1, highly expressed in brain, which has increased affinity for huntingtin protein with expanded polyglutamine repeats. This gene contains an upstream open reading frame in the 5' UTR that inhibits expression of the huntingtin gene product through translational repression. [provided by RefSeq, Jul 2016]
HTT Gene-Disease associations (from GenCC):
  • Huntington disease
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae), Orphanet
  • Lopes-Maciel-Rodan syndrome
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • juvenile Huntington disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -4 ACMG points.

PP5
Variant 4-3074876-C-CCAGCAGCAGCAGCAGCAGCAGCAGCAG is Pathogenic according to our data. Variant chr4-3074876-C-CCAGCAGCAGCAGCAGCAGCAGCAGCAG is described in ClinVar as [Pathogenic]. Clinvar id is 3359130.Status of the report is criteria_provided_single_submitter, 1 stars.
BP3
Nonframeshift variant in repetitive region in NM_001388492.1
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00584 (770/131874) while in subpopulation AMR AF = 0.0088 (118/13410). AF 95% confidence interval is 0.00751. There are 7 homozygotes in GnomAd4. There are 376 alleles in the male GnomAd4 subpopulation. Median coverage is 0. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High Homozygotes in GnomAd4 at 7 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HTTNM_001388492.1 linkc.84_110dupGCAGCAGCAGCAGCAGCAGCAGCAGCA p.Gln29_Gln37dup disruptive_inframe_insertion Exon 1 of 67 ENST00000355072.11 NP_001375421.1
HTTNM_002111.8 linkc.84_110dupGCAGCAGCAGCAGCAGCAGCAGCAGCA p.Gln29_Gln37dup disruptive_inframe_insertion Exon 1 of 67 NP_002102.4 P42858

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HTTENST00000355072.11 linkc.84_110dupGCAGCAGCAGCAGCAGCAGCAGCAGCA p.Gln29_Gln37dup disruptive_inframe_insertion Exon 1 of 67 1 NM_001388492.1 ENSP00000347184.5 P42858

Frequencies

GnomAD3 genomes
AF:
0.00583
AC:
768
AN:
131776
Hom.:
7
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.00469
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00881
Gnomad ASJ
AF:
0.00596
Gnomad EAS
AF:
0.00169
Gnomad SAS
AF:
0.00307
Gnomad FIN
AF:
0.00367
Gnomad MID
AF:
0.0149
Gnomad NFE
AF:
0.00657
Gnomad OTH
AF:
0.00612
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.00200
AC:
2452
AN:
1225710
Hom.:
29
Cov.:
0
AF XY:
0.00215
AC XY:
1308
AN XY:
608048
show subpopulations
African (AFR)
AF:
0.00139
AC:
36
AN:
25810
American (AMR)
AF:
0.00340
AC:
103
AN:
30288
Ashkenazi Jewish (ASJ)
AF:
0.00255
AC:
58
AN:
22734
East Asian (EAS)
AF:
0.00175
AC:
51
AN:
29094
South Asian (SAS)
AF:
0.00234
AC:
169
AN:
72222
European-Finnish (FIN)
AF:
0.00397
AC:
129
AN:
32500
Middle Eastern (MID)
AF:
0.00159
AC:
6
AN:
3782
European-Non Finnish (NFE)
AF:
0.00183
AC:
1753
AN:
957450
Other (OTH)
AF:
0.00284
AC:
147
AN:
51830
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
63
126
190
253
316
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00584
AC:
770
AN:
131874
Hom.:
7
Cov.:
0
AF XY:
0.00593
AC XY:
376
AN XY:
63418
show subpopulations
African (AFR)
AF:
0.00470
AC:
167
AN:
35522
American (AMR)
AF:
0.00880
AC:
118
AN:
13410
Ashkenazi Jewish (ASJ)
AF:
0.00596
AC:
19
AN:
3190
East Asian (EAS)
AF:
0.00170
AC:
7
AN:
4124
South Asian (SAS)
AF:
0.00307
AC:
12
AN:
3910
European-Finnish (FIN)
AF:
0.00367
AC:
27
AN:
7366
Middle Eastern (MID)
AF:
0.0159
AC:
4
AN:
252
European-Non Finnish (NFE)
AF:
0.00659
AC:
405
AN:
61484
Other (OTH)
AF:
0.00606
AC:
11
AN:
1816
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.555
Heterozygous variant carriers
0
32
64
97
129
161
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
452

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Huntington disease Pathogenic:1
Sep 06, 2023
Institute of Human Genetics, University of Leipzig Medical Center
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
4.8
Mutation Taster
=80/20
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs71180116; hg19: chr4-3076603; API